Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

54 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Disease-free survival and the prognostic factors affecting disease-free survival in patients with medullary thyroid carcinoma: a multicenter cohort study.
Zuhur SS, Ozturk BO, Keskin U, Uysal S, Hacioglu A, Avci U, Karsli S, Andac B, Ozbay UN, Kilinc F, Erol S, Catak M, Sodan H, Pekkolay Z, Burhan S, Akbaba G, Ates C, Yorulmaz G, Tekin S, Topcu B, Tuna MM, Kadioglu P, Gonen MS, Karaca Z, Ciftci S, Celik M, Guldiken S, Tuzun D, Altuntas Y, Akturk M, Niyazoglu M, Cinar N, Gul OO, Kebapci MN, Akalin A, Bayraktaroglu T, Elbuken G. Zuhur SS, et al. Among authors: bayraktaroglu t. Endocrine. 2024 Sep;85(3):1300-1309. doi: 10.1007/s12020-024-03809-0. Epub 2024 Apr 3. Endocrine. 2024. PMID: 38570387
Can Age at Diagnosis and Sex Improve the Performance of the American Thyroid Association Risk Stratification System for Prediction of Structural Persistent and Recurrent Disease in Patients With Differentiated Thyroid Carcinoma? A Multicenter Study.
Zuhur SS, Aggul H, Çelik M, Avci U, Erol S, Kilinç F, Akbaba G, Cinar N, Tekin S, Sahin S, Bilen O, Elbuken G, Guldiken S, Kadioglu P, Bayraktaroglu T, Topcu B, Altuntas Y. Zuhur SS, et al. Among authors: bayraktaroglu t. Endocr Pract. 2022 Jan;28(1):30-35. doi: 10.1016/j.eprac.2021.09.001. Epub 2021 Sep 8. Endocr Pract. 2022. PMID: 34508902
The impact of microscopic extrathyroidal extension on the clinical outcome of classic subtype papillary thyroid microcarcinoma: a multicenter study.
Zuhur SS, Aggul H, Avci U, Erol S, Tuna MM, Uysal S, Akbaba G, Kilinc F, Catak M, Tekin S, Ozturk BO, Yavuz HC, Kadioglu P, Cinar N, Bayraktaroglu T, Topcu B, Altuntas Y, Elbuken G. Zuhur SS, et al. Among authors: bayraktaroglu t. Endocrine. 2024 Mar;83(3):700-707. doi: 10.1007/s12020-023-03533-1. Epub 2023 Sep 22. Endocrine. 2024. PMID: 37736822
The effect of gender on response to antithyroid drugs and risk of relapse after discontinuation of the antithyroid drugs in patients with Graves' hyperthyroidism: a multicentre study.
Zuhur SS, Yildiz I, Altuntas Y, Bayraktaroglu T, Erol S, Sahin S, Kilinc F, Akbaba G, Topcu B, Elbuken G, Kadioglu P. Zuhur SS, et al. Among authors: bayraktaroglu t. Endokrynol Pol. 2020;71(3):207-212. doi: 10.5603/EP.a2020.0007. Epub 2020 Mar 10. Endokrynol Pol. 2020. PMID: 32154572 Free article.
Do Histologically Aggressive Subtypes of Papillary Thyroid Microcarcinoma have Worse Clinical Outcome than Non-Aggressive Papillary Thyroid Microcarcinoma Subtypes? A Multicenter Cohort Study.
Zuhur SS, Aggul H, Avci U, Erol S, Tuna MM, Uysal S, Akbaba G, Kilinç F, Catak M, Tekin S, Bilen OI, Öztürk BO, Erden EB, Elbuken G, Yavuz HC, Kadioglu P, Cinar N, Kutluturk F, Bayraktaroglu T, Topçu B, Arslan AI, Gucer H, Cihangiroglu G, Topal CS, Ozturk T, Tekin L, Artas G, Akcay E, Gun BD, Altuntas Y. Zuhur SS, et al. Among authors: bayraktaroglu t. Horm Metab Res. 2023 May;55(5):323-332. doi: 10.1055/a-2032-5810. Epub 2023 Feb 10. Horm Metab Res. 2023. PMID: 36764327 Free article.
Utilization of statins and LDL-cholesterol target attainment in Turkish patients with type 2 diabetes - a nationwide cross-sectional study (TEMD dyslipidemia study).
Bayram F, Sonmez A, Haymana C, Sabuncu T, Dizdar OS, Gurkan E, Carlioglu AK, Agbaht K, Ozdemir D, Demirci I, Barcin C, Salman S, Tetiker T, Balci MK, Kebapci N, Ersoy C, Yumuk V, Toth PP, Satman I; TEMD Study Group. Bayram F, et al. Lipids Health Dis. 2020 Nov 11;19(1):237. doi: 10.1186/s12944-020-01408-2. Lipids Health Dis. 2020. PMID: 33176832 Free PMC article.
A Cross-Sectional Study of Overtreatment and Deintensification of Antidiabetic and Antihypertensive Medications in Diabetes Mellitus: The TEMD Overtreatment Study.
Sonmez A, Tasci I, Demirci I, Haymana C, Barcin C, Aydin H, Cetinkalp S, Ozturk FY, Gul K, Sabuncu T, Satman I, Bayram F; TEMD Study Group. Sonmez A, et al. Diabetes Ther. 2020 May;11(5):1045-1059. doi: 10.1007/s13300-020-00779-0. Epub 2020 Feb 22. Diabetes Ther. 2020. PMID: 32088879 Free PMC article.
Characteristics of patients with hypertension in a population with type 2 diabetes mellitus. Results from the Turkish Nationwide SurvEy of Glycemic and Other Metabolic Parameters of Patients with Diabetes Mellitus (TEMD Hypertension Study).
Sabuncu T, Sonmez A, Eren MA, Sahin I, Çorapçioğlu D, Üçler R, Akin Ş, Haymana C, Demirci İ, Atmaca A, Ersöz HÖ, Satman I, Bayram F; TEMD Study Group. Sabuncu T, et al. Prim Care Diabetes. 2021 Apr;15(2):332-339. doi: 10.1016/j.pcd.2020.11.001. Epub 2020 Dec 1. Prim Care Diabetes. 2021. PMID: 33277201
54 results